Rep. Greg Stanton Sells Trulieve Cannabis Corp. (OTCMKTS:TCNNF) Shares

Representative Greg Stanton (Democratic-Arizona) recently sold shares of Trulieve Cannabis Corp. (OTCMKTS:TCNNF). In a filing disclosed on June 26th, the Representative disclosed that they had sold between $100,001 and $250,000 in Trulieve Cannabis stock on May 28th.

Representative Greg Stanton also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Trulieve Cannabis (OTCMKTS:TCNNF) on 5/6/2026.

Trulieve Cannabis Price Performance

Shares of TCNNF stock opened at $11.55 on Tuesday. The firm’s 50 day moving average price is $9.58 and its two-hundred day moving average price is $8.01. Trulieve Cannabis Corp. has a fifty-two week low of $3.25 and a fifty-two week high of $13.28.

Wall Street Analyst Weigh In

Separately, Alliance Global Partners restated a “buy” rating on shares of Trulieve Cannabis in a research note on Thursday, June 4th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

About Representative Stanton

Greg Stanton (Democratic Party) is a member of the U.S. House, representing Arizona’s 4th Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Stanton (Democratic Party) is running for re-election to the U.S. House to represent Arizona’s 4th Congressional District. He declared candidacy for the 2026 election.

Greg Stanton was born in Long Island, New York. Stanton graduated from Cortez High School. He earned a B.A. in political science and history from Marquette University in 1992 and a J.D. from the University of Michigan in 1995. Stanton’s career experience includes working as the mayor of Phoenix, deputy attorney general of Arizona, as an education attorney, and on the Phoenix City Council.

Trulieve Cannabis Company Profile

Trulieve Cannabis Corp. is a vertically integrated cannabis operator and retailer, offering a full suite of services from cultivation and processing to distribution and sales. The company develops, manufactures and markets a diverse range of cannabis products under its own brand portfolio, serving both medical and adult-use consumers through a network of branded dispensaries and delivery services.

Trulieve’s product lineup includes dried flower, vape cartridges, concentrates, edibles, tinctures and topicals, all of which are produced in compliance with state regulatory requirements.